Composition of thrombi in late drug-eluting stent thrombosis versus de novo acute myocardial infarction

Thrombosis Research

Volumn 126, Issue 3, 2010, Pages 254-257

  Nishihira, Kensaku ^a   Yamashita, Atsushi ^b   Ishikawa, Tetsunori ^a   Hatakeyama, Kinta ^b   Shibata, Yoshisato ^a   Asada, Yujiro ^b  

^a Miyazaki Medical Association Hospital Cardiovascular Center   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

DES thrombosis; Fibrin; P2Y12; Platelet

Indexed keywords

CD16 ANTIGEN; CD34 ANTIGEN; FIBRIN; FIBRINOGEN RECEPTOR; GLYCOPHORIN A; PURINERGIC P2Y12 RECEPTOR; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ARTICLE; ASPIRATION CATHETER; CELL COUNT; CHEMICAL COMPOSITION; CLINICAL ARTICLE; DRUG ELUTING STENT; EOSINOPHIL; ERYTHROCYTE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THROMBOCYTE AGGREGATION; THROMBOSIS; THROMBUS; THROMBUS ASPIRATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; BLOOD PLATELETS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956268674     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.010     Document Type: Article

References (15)

1. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, and G. Stankovic Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
2. T. Kimura, T. Morimoto, Y. Nakagawa, T. Tamura, K. Kadota, and H. Yasumoto Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
3. M. Awata, J. Kotani, M. Uematsu, T. Morozumi, T. Watanabe, and T. Onishi Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents Circulation 116 2007 910 916
4. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, and E. Ladich Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
5. A.V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, and M.C. John Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
6. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
7. A. Yamashita, T. Sumi, S. Goto, Y. Hoshiba, K. Nishihira, and R. Kawamoto Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction Am J Cardiol 97 2006 26 28
8. M.H. Jeong, W.G. Owen, M.E. Staab, S.S. Srivatsa, G. Sangiorgi, and M. Stewart Porcine model of stent thrombosis: platelets are the primary component of acute stent closure Cathet Cardiovasc Diagn 38 1996 38 43
9. Y. Sato, K. Hatakeyama, A. Yamashita, K. Marutsuka, A. Sumiyoshi, and Y. Asada Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans Heart 91 2005 526 530
10. Y. Hoshiba, K. Hatakeyama, T. Tanabe, Y. Asada, and S. Doto Co-localizaion of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction J Thromb Haemost 4 2006 114 120
11. S.D. Wiviott, E. Braunwald, C.H. McCabe, I. Horvath, M. Keltai, and J.P. Herrman Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
12. T. Kamae, M. Shiraga, H. Kashiwagi, H. Kato, S. Tadokoro, and Y. Kurata Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation J Thromb Haemost 4 2006 1379 1387
13. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, and S. Gottlieb Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
14. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, and J.T. Brandt Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
15. J. Aoki, P.W. Serruys, H. van Beusekom, A.T. Ong, E.P. McFadden, and G. Sianos Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry J Am Coll Cardiol 45 2005 1574 1579